Physician profile
Ker Boyce
NPI 1962441808
$10,239.29
in general payments reported to CMS, 2019-2025
43 companies · $2,026 in 2025
The $2,026 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,446 · 2020: $126 · 2021: $487 · 2022: $984 · 2023: $2,822 · 2024: $1,348 · 2025: $2,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,240 · Travel and Lodging: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,240.37 |
| Travel and Lodging | $955.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,014.78 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $443.55 | 2019-2025 | Lifevest |
| Abbott Laboratories | $419.16 | 2019-2025 | Jot Dx, Cardiomems, Diamondback Coronary |
| Medtronic, INC. | $331.08 | 2021-2025 | Pulseselect, Cobalt Dr Mri Surescan, Micra |
| Biosense Webster, INC. | $273.55 | 2022-2024 | Na, Qdot Micro Catheter |
| E.R. Squibb & Sons, L.L.C. | $249.82 | 2019-2025 | Camzyos |
| Astrazeneca Pharmaceuticals Lp | $245.83 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Abiomed | $231.72 | 2020-2025 | Impella |
| Pfizer INC. | $205.84 | 2019-2025 | |
| Atricure, INC. | $183.25 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System |
| Janssen Pharmaceuticals, INC | $181.89 | 2019-2024 | Xarelto |
| Cleerly, INC. | $175.00 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Alnylam Pharmaceuticals INC. | $132.94 | 2019 | |
| Angiodynamics, INC. | $108.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $105.71 | 2019-2023 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $91.82 | 2024 | |
| Merck Sharp & Dohme LLC | $73.92 | 2022-2023 | Verquvo |
| Cardiva Medical, INC. | $65.77 | 2023-2025 | Savvywire, Cardiva Vascade 6/7f Vcs, Optowire |
| Philips North America LLC | $65.73 | 2022 | |
| Sanofi-Aventis U.S. LLC | $63.33 | 2019 | |
| Ethicon US, LLC | $59.63 | 2025 | Surgicel Nu-Knit, Stratafix, Dermabond |
| Amgen INC. | $58.02 | 2019-2022 | |
| Terumo Medical Corporation | $51.31 | 2019-2025 | Metacross Otw, Angio-Seal, Heartrail |
| Edwards Lifesciences Corporation | $50.70 | 2021-2024 | Sapien 3 Ultra Resilia |
| Lundbeck LLC | $33.68 | 2019-2020 | |
| Novo Nordisk INC | $31.36 | 2021-2024 | Ozempic, Rybelsus |
| Regeneron Healthcare Solutions, INC. | $24.95 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $24.04 | 2024 | Arcalyst |
| Inari Medical, INC. | $22.28 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cordis US Corp. | $21.97 | 2025 | Mynx Control Venous |
| Teleflex LLC | $19.75 | 2025 | Vascband |
| Impulse Dynamics (USA) INC. | $19.36 | 2021 | |
| Cardiovascular Systems INC. | $18.81 | 2022 | |
| Altathera Pharmaceuticals LLC | $17.47 | 2025 | Sotalol Hydrochloride |
| Braemar Manufacturing, LLC | $14.97 | 2019 | |
| Amarin Pharma, INC. | $14.47 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.42 | 2025 | |
| Biotronik INC. | $14.34 | 2019 | |
| Cook Medical LLC | $14.14 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.83 | 2019 | |
| Astellas Pharma US INC | $13.08 | 2019 | |
| Medtronic Vascular, INC. | $11.93 | 2019 | |
| Irhythm Technologies, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ker Boyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.